AbCellera Biologics (ABCL) Shares Issued (2021 - 2022)

AbCellera Biologics' (ABCL) quarterly Shares Issued came in at $22.5 million in Q3 2022, up 25.01% YoY from $18.0 million in Q3 2021, and up 8.45% on a QoQ basis from $20.7 million in Q2 2022.

AbCellera Biologics (ABCL) Shares Issued (2021 - 2022) Analysis & Trends

AbCellera Biologics (ABCL) has 2 years of Shares Issued data on file, last reported at $22.5 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 18.36 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 AbCellera Biologics 3.49 Bn 3.49 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 22.46 Mn
Sep 30, 2022 22.46 Mn
Jun 30, 2022 20.71 Mn
Jun 30, 2022 20.71 Mn
Mar 31, 2022 37.53 Mn
Mar 31, 2022 37.53 Mn
Sep 30, 2021 17.96 Mn
Sep 30, 2021 17.96 Mn
Jun 30, 2021 45.68 Mn
Jun 30, 2021 45.68 Mn
Mar 31, 2021 1.58 Mn
Mar 31, 2021 1.58 Mn